New cancer clinical trial: Objective Evaluation of Paclitaxel/Docetaxel-induced Neuropathy in Breast Cancer Patients

Published on: March 13, 2019 at 06:00PM
Conditions:   Breast Cancer;   Chemotherapy Induced Peripheral Neuropathy;   Paclitaxel Induced Neuropathy
Intervention:   Diagnostic Test: Quantitative measures of reduction in Chemotherapy Induced Neuropathy (CIPN) and Cognitive Impairment (CICI) in patients with stage I-III breast cancer
Sponsor:   Yale University
Recruiting